We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Nastech CEO Presents RNA Interference Pandemic Influenza Program at Beyond Genome Conference
News

Nastech CEO Presents RNA Interference Pandemic Influenza Program at Beyond Genome Conference

Nastech CEO Presents RNA Interference Pandemic Influenza Program at Beyond Genome Conference
News

Nastech CEO Presents RNA Interference Pandemic Influenza Program at Beyond Genome Conference

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Nastech CEO Presents RNA Interference Pandemic Influenza Program at Beyond Genome Conference"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Steven C. Quay, M.D., Ph.D., Chairman, President and CEO of Nastech Pharmaceutical Company Inc. has presented the company’s RNAi pandemic influenza program at Cambridge Healthtech Institute’s 5th annual RNA Interference conference.

Dr. Quay’s presentation summarized the results and status of Nastech’s siRNA pandemic influenza program and the company’s RNAi platform technology, delivery technology, and pre-clinical success with continued progression toward human clinical trials.

Advertisement